Comments on ‘Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer’

Detalles Bibliográficos
Autores principales: Takada, K., Takamori, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547230/
https://www.ncbi.nlm.nih.gov/pubmed/36208495
http://dx.doi.org/10.1016/j.esmoop.2022.100599
_version_ 1784805218811117568
author Takada, K.
Takamori, S.
author_facet Takada, K.
Takamori, S.
author_sort Takada, K.
collection PubMed
description
format Online
Article
Text
id pubmed-9547230
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-95472302022-10-09 Comments on ‘Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer’ Takada, K. Takamori, S. ESMO Open Correspondence Elsevier 2022-10-05 /pmc/articles/PMC9547230/ /pubmed/36208495 http://dx.doi.org/10.1016/j.esmoop.2022.100599 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Takada, K.
Takamori, S.
Comments on ‘Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer’
title Comments on ‘Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer’
title_full Comments on ‘Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer’
title_fullStr Comments on ‘Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer’
title_full_unstemmed Comments on ‘Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer’
title_short Comments on ‘Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer’
title_sort comments on ‘biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer’
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547230/
https://www.ncbi.nlm.nih.gov/pubmed/36208495
http://dx.doi.org/10.1016/j.esmoop.2022.100599
work_keys_str_mv AT takadak commentsonbiomarkersofsystemicinflammationpredictsurvivalwithfirstlineimmunecheckpointinhibitorsinnonsmallcelllungcancer
AT takamoris commentsonbiomarkersofsystemicinflammationpredictsurvivalwithfirstlineimmunecheckpointinhibitorsinnonsmallcelllungcancer

Ejemplares similares